Triphenylethylene anti-oestrogens. such as tamoxifen, are thought to reverse oestrogen stimulated events by a mechanism which involves their occupying the oestrogen receptor. However. there is evidence to suggest tamoxifen may have other effects such as inhibiting calmodulin-mediated events (Lam, 1984) . We have investigated the effect of tamoxifen on thyrotropin releasing hormone (TRH) induction of rat prolactin (Prl) gene transcription in GH, cells and observe that it inhibits it: it is possible that this effect is mediated by an oestrogen-receptor-independent mechanism.
Transcriptional studies were carried out using a plasmid prPrl-CAT (chloramphenicol acetyl transferase) (T. Lufkin & C. Bancroft, unpublished work) which contains 2 kb of rat prolactin gene immediate 5'-flanking sequence and the CAT construct from pRSV-CAT which can be expressed in eukaryotic cells (Gorman et a/., 1982) . Transient transfection of prPrl-CAT into G H , cells (2 x 10' cells per 60mm dish) was carried out by placing the plasmid (10 pgt-DEAE dextran mixture on the cells for 1 h at 37°C. This solution was then aspirated, the cells exposed to 10% ( v i v ) glycerol for 1 min. washed with Dulbecco's modified Eagle's medium (DMEM) three times and then incubated with DMEM containing 12.5% horse serum and 2.5% (v/v) fetal calf serum at 37°C in a humidified atmosphere containing 9% CO?, for 48 h. In some experiments the same medium/serum preparation which had been 'hormonedepleted' by ion-exchange resin and charcoal treatment was employed. TRH (27 n~) , oestradiol (10 '-10 "'M) and/or tamoxifen (10 or 10 ' M ) were incorporated into the culture medium. To assess chloramphenicol acetyl transferase activity the cells were harvested after 48 h and sonicated, and a cytosolic extract isolated by centrifugation. This was Transient transfection of prPrl-CAT into GH, cells resulted in transcription from the rat prolactin promoter as judged by the presence of measurable CAT activity. TRH (27 nM) increased CAT gene expression by 2.7-fold (mean of five experiments). Tamoxifen (lo-' M) significantly reversed the TRH-induced increase in CAT activity ( p < 0.05, n = 4). Tamoxifen alone had no effect on basal CAT activity levels. Oestradiol ( 1 0~7 -1 0~i "~) induced increases in CAT gene expression in prPrL-CAT transfected GH, cells of between 1.8-and 2.9-fold which again could be reversed by Tamoxifen (10 -5 M ) . These effects were observed in cells cultured in normal and in hormone depleted serum.
These findings parallel our previous observation that tamoxifen can reverse both oestradiol-and TRH-induced increases in prolactin-specific mRNA levels in GH, cells as measured by both cytoplasmic dot hybridization and Northern analysis.
Thus, tamoxifen can inhibit both TRH and oestradiolinduced increases in transcription from the rat prolactin promoter in GH, cells. There is little reason to suspect that TRH induction of prolactin gene transcription in GH, cells is oestrogen requiring, therefore, we would suspect that tamoxifen inhibition of the TRH effect might be mediated by an oestrogen-receptor independent mechanism. Much evidence suggests that a subclass of nuclear proteins interacts with specific DNA sequences in gene promoters and exerts permissive or modulatory activities on gene expression. We were interested in identifying and characterizing nuclear proteins which bind preferentially to the 5'-flanking region of the rat prolactin gene. To this end protection against exonuclease 111 digestion has been used to determine the rat prolactin (Prl) promoter sequences to which nucelar proteins from pituitary cells will bind.
Abbreviations used: RSV, Rous sarcoma virus; Prl, prolactin; LTR, long terminal repeat.
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Nuclear extracts from GH, and HeLa cells were prepared by the method of Dignam et a/. (1983) . The following promoter sequences were 5'-strand specifically "P-labelled: ( a ) a 565 bp HindIII-Arc1 fragment of the rat prolactin gene Hindlll site. Exonuclease 111 protection assays were carried out essentially as described by Wu (1985) : 1-3 ng of endlabelled DNA (3-6000c.p.m.), carrier DNA and nuclear or whole cell extract, in binding buffer, were incubated at 24°C for 15 min to achieve DNA-protein binding; exonuclease 111 (Boehringer) was added and the mixture incubated for 10 min at 30°C. The reaction was stopped by the addition of an EDTA/salt/SDS solution and the DNA purified, precipitated and analysed on 5% urea-saturated polyacryl-amide sequcncing gels. The gels were autoradiographcd at -70°C with intensifying screens.
The transcriptional competence of the nuclear and whole cell extracts were tested in in vitro transcription reactions (Manley. 1983 ) using as templates a cloned adenovirus fragment containing the major late promoter and downstream sequences ( S m i l cut p B a l E ) and a cloned rat prolactin gene fragment, containing the promoter and downstream sequences ( - Exonuclease 111 protection analysis of GH, cell nuclear proteins binding to the rat prolactin promoter identified four major borders of protection at ~ 30, -47, -69 and -16 I (exonuclease I I I digestion proceeding from proximal to distal through the promoter; start site of transcription, + 1) and at -56, -66, -76 and ~ 180 (exonuclease I l l digestion proceeding distal to proximal through the promoter). In both cases, these borders of protection differed from those labelled fragments which were observed when exonuclease 111 digested the template DNA in the absence of added nuclear extract. This pattern of protection was not observed when HeLa nuclear or whole cell extracts (Manley ct d.. 1980) were substituted for the GH, cell extracts. While the HeLa extracts showed only very weak ability to protect the prolactin promoter fragments from exonuclease I11 digestion they were transcriptionally competent as judged by their ability to drive transcription from both the adenomajor late and rat prolactin promoters in vitro; the GH, cell extracts studied were similarly transcriptionally competent.
We have preliminary data to suggest that both the GH, and HeLa nuclear extracts produce the same pattern of protection from exonuclease 111 digestion on an RSV-~LTR fragment. These observations suggest that pattern of protection of the proximal rat prolactin promoter sequences by GH, cell nuclear proteins is a cell-specific phenomenon. We have further preliminary evidence to suggest that this pattern of protection can be competed away by an excess of unlabelled rat prolactin or growth hormone promoter fragment, but not by an excess of RSV-LTR, or Moloney leukaemia virus LTR sequences.
These findings are in broad agreement with the pattern of protection from exonuclease 111 digestion of proximal rat prolactin promoter sequences by GH, cell nuclear extracts described by Elsholtz et al. (1986) . Our observation of the cell specific nature of these interactions is interesting in view of the recent description of a G C cell-specific protection of a proximal region of the rat growth hormone promoter from DNase I digestion (West c't ul., 1987) Variation in transcriptional activity of enhancer deleted Rous sarcoma virus (RSV) LTR in eukaryotic cell types Transient transfection of plasmids into C, and C127 cells was carried out by placing a calcium phosphate precipitate containing 10pg plasmid on 60mm petri dishes containing 2 x 10' cells; the dishes were then maintained at 37°C for 4 h; transient transfection into GH, cells was carried out by placing plasmids (IOpg) in a DEAE dextran solution 2 x 10' cells in 60mm petri dishes for 1 h. at 37°C. In both cases the transfecting solutions were then aspirated, the cells exposed to 10% (w/v) glycerol for 1 min, washed with Dulbecco's modified Eagle's medium (DMEM) three times and then, incubated with DMEM containing 12.5% horse serum and 2.5% ( v h ) fetal calf serum (GH, cells) and 10.0% fetal calf serum (C, and C127 cells) at 37" in a humidified atmosphere containing 9% CO,. for 48 h.
T o assess chlorampenicol acetyl transferase activity the cells were harvested and sonicated, and a cytosolic extract isolated by centrifugation. This was incubated with ['4C]chloramphenicol (0.1 pCi. specific activity 54 mCimmol I ) in the presence of acetyl-coenzyme A (4.0 mM) at 37" for 2 h; the incubation mixture was then extracted with ethyl acetate and this extract analysed by t.1.c.: the levels of acetylated ['4C]chloramphenicol metabolites formed were assessed by autoradiography and quantified by scintillation counting. Results were calculated in each case. from the mean of at least three independent transfection experiments.
The SV-40 enhancer-promoter in pSV2 CAT showed
